Toronto Stocks Climb, Loblaw Shares Rise on 4Q Profit, Revenue Growth
By Adriano Marchese
Toronto stocks were firmly higher, with a broad-based positive performance among Canada's sectors.
Canadian tech was the largest gainer in Thursday's session, followed by commercial services and health tech. Materials, distribution services and consumer discretionary led the few decliners.
On the macro front, Canadian consumers pulled back on spending in January following a strong increase in retail purchases over the holiday season, a possible sign of household budget strain from high interest rates.
At midday, Canada's S&P/TSX Composite Index was 0.59% higher at 21298.30 while the blue-chip S&P/TSX 60 rose by 0.68% to 1287.33.
Loblaw shares were 2% higher at 140.93 Canadian dollars after reporting increased profit and higher revenue growth in the fourth quarter as customers continued to gravitate toward its discount banners amid stubbornly higher food prices in Canada.
Other market movers:
Maple Leaf Foods shares were 6.3% lower at C$24.20 after reporting adjusted earnings and revenue growth that missed expectations in the fourth quarter as its plant protein segment continues to face challenges.
Shares in Bausch Health were 7% higher at C$12.50 after it reported a narrowed loss and better-than-expected revenue, and said it expects the growth momentum to continue in 2024.
Quebecor shares fell by 3.9% to C$30.30 after reporting a slight decline in profit in the fourth quarter while revenue beat expectations, driven largely by the addition of Freedom Mobile to its network.
Cascades shares fell by nearly 19% to C$12.02 after the company reported a wider loss and flat revenue in its fourth quarter, missing analyst expectations. It projected a softer performance in the first quarter.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
February 22, 2024 12:26 ET (17:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track